Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disease of the Marrow”

1,994 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,994 results

Not applicableEnrolling By InvitationNCT07023692
What this trial is testing

Visual and Auditory Distraction for the Relief of Pain and Anxiety

Who this might be right for
Bone Marrow AspirationPainAnxiety+4 more
Region Skane 250
Testing effectiveness (Phase 2)Study completedNCT00445900
What this trial is testing

Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid Metaplasia

Who this might be right for
Chronic Myeloproliferative DisordersSecondary Myelofibrosis
Mayo Clinic 22
Testing effectiveness (Phase 2)Study completedNCT03593200
What this trial is testing

A Phase IIa Study to Assess the Safety, Efficacy, and Pharmacokinetics of Subcutaneously Administered Pegcetacoplan (APL-2) in Subjects With PNH

Who this might be right for
PNH
Apellis Pharmaceuticals, Inc. 4
Large-scale testing (Phase 3)Active Not RecruitingNCT06514807
What this trial is testing

Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythaemia Patients

Who this might be right for
Essential Thrombocythaemia
AOP Orphan Pharmaceuticals AG 117
Testing effectiveness (Phase 2)Study completedNCT00054600
What this trial is testing

Safety and Efficacy Study of Photopheresis With UVADEX to Prevent Graft-versus-Host Disease

Who this might be right for
Graft-versus-Host Disease
Mallinckrodt 60
Testing effectiveness (Phase 2)UnknownNCT00885508
What this trial is testing

The Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5q

Who this might be right for
Myelodysplastic SyndromeChronic Myelomonocytic LeukemiaAcute Myeloid Leukemia
Groupe Francophone des Myelodysplasies 85
Testing effectiveness (Phase 2)WithdrawnNCT05323617
What this trial is testing

Efficacy of Romiplostim in Treatment of SAA in Adults Previously Untreated With or Refractory to Immunosuppressive Therapy

Who this might be right for
Severe Aplastic Anemia (SAA)
Amgen
Not applicableStudy completedNCT03130335
What this trial is testing

Intra-articular Autologous Bone Marrow Aspirate Injection for Knee Osteoarthritis

Who this might be right for
Osteoarthritis, Knee
Hospital for Special Surgery, New York 13
Testing effectiveness (Phase 2)Study completedNCT01860417
What this trial is testing

Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV)

Who this might be right for
Degenerative Disc DiseaseIntervertebral Disc DiseaseLow Back Pain
Red de Terapia Celular 24
Testing effectiveness (Phase 2)UnknownNCT01914913
What this trial is testing

Clinical Study to Evaluate Safety and Efficacy of BMMNC in Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
Chaitanya Hospital, Pune 15
Testing effectiveness (Phase 2)Ended earlyNCT04519697
What this trial is testing

Mesenchymal Stem Cells for the Treatment of Rectovaginal Fistulas in Participants With Crohn's Disease

Who this might be right for
Rectovaginal FistulaCrohn DiseaseCrohn Disease of Vulva+1 more
Anthony Lembo 20
Testing effectiveness (Phase 2)Study completedNCT00455910
What this trial is testing

Thalidomide at Low Dose for the Treatment of Patient With Myelodysplastic Syndromes - THAL-SMD-200

Who this might be right for
Myelodysplastic Syndromes
Groupe Francophone des Myelodysplasies 112
Not applicableStudy completedNCT04522505
What this trial is testing

Long-term Follow-up for Evaluating the Safety of CS20AT04 in Subject with Lupus Nephritis

Who this might be right for
Lupus Nephritis
Corestemchemon, Inc. 6
Testing effectiveness (Phase 2)WithdrawnNCT04629651
What this trial is testing

Captopril Use on the Degree of Marrow Fibrosis in Bone Marrow Fibrosis/Myeloproliferative Neoplasms

Who this might be right for
Bone Marrow FibrosisMyeloproliferative Neoplasm
Case Comprehensive Cancer Center
Not applicableStudy completedNCT03099031
What this trial is testing

Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE)

Who this might be right for
Venous Thromboembolism
LEO Pharma 420
Testing effectiveness (Phase 2)Study completedNCT01120821
What this trial is testing

Treatment of Polycythemia Vera With Gleevec

Who this might be right for
Polycythemia Vera
Weill Medical College of Cornell University 36
Not applicableStudy completedNCT00281814
What this trial is testing

Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
The Cleveland Clinic 36
Early research (Phase 1)WithdrawnNCT03807063
What this trial is testing

Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell Transplant

Who this might be right for
Acute Bilineal LeukemiaMyelodysplastic/Myeloproliferative NeoplasmMyelodysplastic/Myeloproliferative Neoplasm, Unclassifiable+9 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00096096
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT01433445
What this trial is testing

Panobinostat and Ruxolitinib in Primary Myelofibrosis, Post-polycythemia Vera-myelofibrosis or Post-essential Thrombocythemia-myelofibrosis

Who this might be right for
Idiopathic MyelofibrosisPost Essential Thrombocythemia MyelofibrosisPost Polycythemia-Vera Myelofibrosis
Novartis Pharmaceuticals 61
Next Page